Notice2026-10090
Exempt Chemical Preparations Under the Controlled Substances Act
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 20, 2026
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
The applications for exempt chemical preparations received by the Drug Enforcement Administration between July 1, 2025, and March 31, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through March 31, 2026, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published. This order also corrects the listing of several preparations that were published in the Federal Register notice on March 20, 2026.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 97 (Wednesday, May 20, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 97 (Wednesday, May 20, 2026)]
[Notices]
[Pages 29505-29510]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-10090]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-372]
Exempt Chemical Preparations Under the Controlled Substances Act
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Order with opportunity for comment.
-----------------------------------------------------------------------
[[Page 29506]]
SUMMARY: The applications for exempt chemical preparations received by
the Drug Enforcement Administration between July 1, 2025, and March 31,
2026, as listed below, were accepted for filing and have been approved
or denied as indicated. This publication addresses preparations through
March 31, 2026, that were not included in previous Federal Register
notices, and it does not affect preparations that have been previously
published. This order also corrects the listing of several preparations
that were published in the Federal Register notice on March 20, 2026.
DATES: Comments must be submitted electronically or postmarked on or
before July 20, 2026.
ADDRESSES: Interested persons may file written comments on this order
in accordance with 21 CFR 1308.23(e). The electronic Federal Docket
Management System will not accept comments after 11:59 p.m. Eastern
Time on the last day of the comment period. To ensure proper handling
of comments, please reference ``Docket No. DEA-372'' on all
correspondence, including any attachments.
<bullet> Electronic comments: The Drug Enforcement Administration
(DEA) encourages that all comments be submitted through the Federal
eRulemaking Portal, which provides the ability to type short comments
directly into the comment field on the web page or to attach a file for
lengthier comments. Please go to <a href="http://www.regulations.gov">http://www.regulations.gov</a> and follow
the online instructions at that site for submitting comments. Upon
completion of your submission, you will receive a Comment Tracking
Number for your comment. Please be aware that submitted comments are
not instantaneously available for public view on <a href="http://Regulations.gov">Regulations.gov</a>. If
you have received a comment tracking number, your comment has been
successfully submitted and there is no need to resubmit the same
comment.
<bullet> Paper comments: Paper comments that duplicate the
electronic submission are not necessary and are discouraged. Should you
wish to mail a comment in lieu of an electronic comment, it should be
sent via regular or express mail to: Drug Enforcement Administration,
Attention: DEA Federal Register Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
<bullet> Paperwork Reduction Act Comments: All comments concerning
collections of information under the Paperwork Reduction Act must be
submitted to the Office of Information and Regulatory Affairs, OMB,
Attention: Desk Officer for DOJ, Washington, DC 20503. Please state
that your comment refers to Docket No. DEA-1189.
FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion
Control Division, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571)
362-8201.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received in response to this docket
are considered part of the public record. The Drug Enforcement
Administration (DEA) will make comments available for public inspection
online at <a href="http://www.regulations.gov">http://www.regulations.gov</a>. Such information includes
personal or business identifiers (such as name, address, state or
Federal identifiers, etc.) voluntarily submitted by the commenter.
Generally, all information voluntarily submitted by the commenter,
unless clearly marked as Confidential Information in the method
described below, will be publicly posted. Comments may be submitted
anonymously. The Freedom of Information Act applies to all comments
received.
Commenters submitting comments which include personal identifying
information (PII), confidential, or proprietary business information
that the commenter does not want made publicly available should submit
two copies of the comment. One copy must be marked ``CONTAINS
CONFIDENTIAL INFORMATION'' and should clearly identify all PII or
business information the commenter does not want to be made publicly
available, including any supplemental materials. DEA will review this
copy, including the claimed PII and confidential business information,
in its consideration of comments. The second copy should be marked ``TO
BE PUBLICLY POSTED'' and must have all claimed confidential PII and
business information already redacted. DEA will post only the redacted
comment on <a href="http://www.regulations.gov">http://www.regulations.gov</a> for public inspection.
For easy reference, an electronic copy of this document and
supplemental information to this proposed scheduling action are
available at <a href="http://www.regulations.gov">http://www.regulations.gov</a>.
Legal Authority
Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811)
authorizes the Attorney General, by regulation, to exempt from certain
provisions of the CSA certain compounds, mixtures, or preparations
containing a controlled substance, if he finds that such compounds,
mixtures, or preparations meet the requirements detailed in 21 U.S.C.
811(g)(3)(B).\1\ DEA regulations at 21 CFR 1308.23 and 1308.24 further
detail the criteria by which the DEA Assistant Administrator may exempt
a chemical preparation or mixture from certain provisions of the CSA.
The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify
or revoke the criteria by which exemptions are granted and modify the
scope of exemptions at any time.
---------------------------------------------------------------------------
\1\ This authority has been delegated from the Attorney General
to the DEA Administrator by 28 CFR 0.100, and subsequently
redelegated to the Deputy Assistant Administrator pursuant to 28 CFR
0.104 and Section 7 of the appendix to subpart R of part 0.
---------------------------------------------------------------------------
Exempt Chemical Preparation Applications Submitted Between July 1,
2025, and March 31, 2026
DEA received applications between July 1, 2025, and March 31, 2026,
requesting exempt chemical preparation status detailed in 21 CFR
1308.23. This publication addresses preparations through March 31,
2026, that were not included in previous Federal Register notices, and
it does not affect preparations that have been previously published.
Additionally, this order corrects the listing of several preparations
that were incorrectly listed in the previous Federal Register notice
dated, March 20, 2026. The company name, product name, and/or form have
been corrected. Pursuant to the criteria stated in 21 U.S.C.
811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has
found that each of the compounds, mixtures, and preparations described
in Chart I below is intended for laboratory, industrial, educational,
or special research purposes and not for general administration to a
human being or animal and either: (1) contains no narcotic controlled
substance and is packaged in such a form or concentration that the
packaged quantity does not present any significant potential for abuse;
or (2) contains either a narcotic or non-narcotic controlled substance
and one or more adulterating or denaturing agents in such a manner,
combination, quantity, proportion, or concentration that the
preparation or mixture does not present any potential for abuse and, if
the preparation or mixture contains a narcotic controlled substance, is
formulated in such a manner that it incorporates methods of denaturing
or other means so that the preparation or mixture is not liable to be
abused or have ill effects, if abused, and so that
[[Page 29507]]
the narcotic substance cannot in practice be removed.
Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23,
and 21 CFR 1308.24, the Assistant Administrator has determined that
each of the chemical preparations or mixtures generally described in
Chart I below and specifically described in the application materials
received by DEA is exempt, to the extent described in 21 CFR 1308.24,
from application of sections 302, 303, 305, 306, 307, 308, 309, 1002,
1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA,
and 21 CFR 1301.74, as of the date that was provided in the approval
letters to the individual requesters.
Scope of Approval
The exemptions are applicable only to the precise preparation or
mixture described in the application submitted to DEA in the form(s)
listed in this order and only for those above-mentioned sections of the
CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in
the quantitative or qualitative composition of the preparation or
mixture, or change in the trade name or other designation of the
preparation or mixture after the date of application requires a new
application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply
to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA
may prescribe requirements other than those set forth in 21 CFR
1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk
quantities. Accordingly, in order to limit opportunities for diversion
from the larger bulk quantities, DEA has determined that each of the
exempted bulk products listed in this order may only be used in-house
by the manufacturer, and may not be distributed for any purpose, or
transported to other facilities.
Additional exempt chemical preparation requests received between
January 1, 2026, and March 31, 2026, and not otherwise referenced in
this order or in prior orders, may remain under consideration until DEA
receives additional information required, pursuant to 21 CFR
1308.23(d), as detailed in separate correspondence to individual
requesters. DEA's order on such requests will be communicated to the
public in a future Federal Register publication.
DEA also notes that these exemptions are limited to exemption from
only those sections of the CSA and the CFR that are specifically
identified in 21 CFR 1308.24(a). All other requirements of the CSA and
the CFR apply, including registration as an importer as required by 21
U.S.C. 957.
Chart I
----------------------------------------------------------------------------------------------------------------
Application
Supplier name Product name Form date
----------------------------------------------------------------------------------------------------------------
Cayman Chemical Company................ Alprazolam (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
methanol.
Cayman Chemical Company................ Alprazolam-d5 (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
methanol.
Cayman Chemical Company................ Clonazepam (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
acetonitrile.
Cayman Chemical Company................ Custom 13-Phytocannabinoid Glass ampule: 1 mL....... 1/19/2026
Mixture (CRM)--AIT (500 [mu]g/
mL each in Acetonitrile).
Cayman Chemical Company................ Custom Phytocannabinoid Glass ampule: 1 mL....... 1/29/2026
Mixture 3, 1 mg/mL ea in
acetonitrile.
Cayman Chemical Company................ Flunitrazepam (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
acetonitrile.
Cayman Chemical Company................ Flunitrazepam (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
methanol.
Cayman Chemical Company................ Lorazepam (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
acetonitrile.
Cayman Chemical Company................ Lorazepam-13C2-d4 (CRM) 0.1 mg/ Glass ampule: 2 mL....... 3/17/2026
mL in acetonitrile.
Cayman Chemical Company................ Lorazepam-13C2-d4 (CRM) 1 mg/ Glass ampule: 2 mL....... 3/17/2026
mL in acetonitrile.
Cayman Chemical Company................ Lorazepam-d4 (CRM) 1 mg/mL in Glass ampule: 2 mL....... 3/17/2026
acetonitrile.
Cayman Chemical Company................ Methylmethcathinone Isomer Glass ampule: 1 mL....... 10/1/2025
Mixture 1 mg/mL in methanol.
Cayman Chemical Company................ Methylmethcathinone Isomer Glass ampule: 1 mL....... 10/1/2025
Mixture 100 [mu]g/mL in
methanol.
Cayman Chemical Company................ Phytocannabinoid Mixture 3 Glass ampule: 1 mL....... 1/29/2026
(CRM) 1 mg/mL ea in
acetonitrile.
Cayman Chemical Company................ [Delta]8-THC-C9 (CRM) 1 mg/mL Glass ampule: 1 mL....... 10/1/2025
in acetonitrile.
Cayman Chemical Company................ [Delta]9-THC (CRM) 1 mg/mL in Glass ampule: 1 mL....... 1/29/2026
acetonitrile.
Cayman Chemical Company................ [Delta]9-THC (CRM) 100 [mu]g/ Glass ampule: 1 mL....... 1/29/2026
mL in acetonitrile.
Cayman Chemical Company................ [Delta]9-THCA-B (CRM) 1 mg/mL Glass ampule: 1 mL....... 10/1/2025
in acetonitrile.
Cayman Chemical Company................ [Delta]9-THCA-B (CRM) 1 mg/mL Glass ampule: 1 mL....... 10/1/2025
in methanol.
Cayman Chemical Company................ [Delta]9-THCA-B (CRM) 100 Glass ampule: 1 mL....... 10/1/2025
[mu]g/mL in acetonitrile.
Cayman Chemical Company................ [Delta]9-THCA-B (CRM) 100 Glass ampule: 1 mL....... 10/1/2025
[mu]g/mL in methanol.
Cayman Chemical Company................ [Delta]9-THCB Butanoate (CRM) Glass ampule: 1 mL....... 10/1/2025
1 mg/mL in acetonitrile.
Cayman Chemical Company................ [Delta]9-THC-C9 (CRM) 1 mg/mL Glass ampule: 1 mL....... 10/1/2025
in acetonitrile.
Cayman Chemical Company................ [Delta]9-THC-d9 (CRM) 1 mg/mL Glass ampule: 1 mL....... 1/29/2026
in acetonitrile.
Cayman Chemical Company................ [Delta]9-THC-d9 (CRM) 100 Glass ampule: 1 mL....... 1/29/2026
[mu]g/mL in acetonitrile.
Cerilliant Corporation................. Buprenorphine Related Compound Glass ampule: 2 mL....... 1/29/2026
A 1.0 mg/mL solvent.
CPI International...................... Custom Cannabinoid mixture 3- Glass ampule: 0.5 mL..... 2/4/2026
0539 1000 ug/mL, 0.5 mL (ISO
17034) Z-G34-140539-01.
CPI International...................... Custom Cannabinoid mixture 7- Glass ampule: 0.5 mL..... 2/4/2026
0538 1000 ug/mL, 0.5 mL (ISO
17034) Z-G34-140538-01.
LGC--Dr. Ehrenstorfer.................. Custom 1-Methylamino-1-(3,4- Amber ampule: 1 mL....... 9/24/2025
methylenedioxyphenyl)-propane
Hydrochloride 10 ug/mL in
Acetonitrile.
LGC--Dr. Ehrenstorfer.................. Custom Hormone Mixture 17762 Glass ampule: 5 mL....... 2/17/2026
100 ug/mL in Methanol DRE-
Q60017762.
LGC--Dr. Ehrenstorfer.................. Custom p-Hydroxycocaine Pack: 5 x 1 mL glass 3/4/2026
Hydrochloride 100 ug/mL in ampules.
Acetonitrile DRE-Q60020132.
LGC-Lipomed............................ 4-Methylmethcathinone HCl Glass ampule: 1 ml....... 8/5/2025
(Mephedrone), 1mg/ml in
Methanol (as free base).
LGC-Lipomed............................ 4-MethylmethcathinoneD3 HCl Glass Ampule: 1 ml....... 10/13/2025
(Mephedrone) 0.1mg/ml in
Methanol (as free base).
LGC-Lipomed............................ Phenobarbital-D5 (side chain), Glass Ampule: 1 ml....... 8/12/2025
0.1 mg/ml in Methanol Prod
No: LPM-PHB-1720-FA-0.1LM.
Lin-Zhi International.................. FEN Validation Sample Set 1... Set: 3 tubes, 10 ml each. 7/18/2025
Lin-Zhi International.................. FEN Validation Sample Set 2... Set: 9 tubes, 10 ml each. 7/18/2025
Lin-Zhi International.................. FEN Validation Sample Set 3... Set: 4 tubes, 30 ml each. 7/18/2025
Lin-Zhi International.................. FEN Validation Sample Set 4... Set: 2 tubes,10 ml each.. 7/18/2025
Lin-Zhi International.................. FEN Validation Sample Set 5... Set: 52 vials, 1 ml each. 7/18/2025
Lin-Zhi International.................. LZI Barbiturate Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Secobarbital,
Cutoff Calibrator Ref# S0143b.
[[Page 29508]]
Lin-Zhi International.................. LZI Barbiturate Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Secobarbital,
High Calibrator Ref# S0145b.
Lin-Zhi International.................. LZI Barbiturate Calibrator/ Dropper bottle: 5 mL..... 2/26/2026
Control (Oral Fluid)
Secobarbital, Intermediate
Calibrator/Level 2 Control
Ref# S0148b.
Lin-Zhi International.................. LZI Barbiturate Calibrator/ Dropper bottle: 5 mL..... 2/26/2026
Control (Oral Fluid)
Secobarbital, Low Calibrator/
Level 1 Control Ref# S0147b.
Lin-Zhi International.................. LZI Benzodiazepine Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Oxazepam, Cutoff
Calibrator Ref# S0133c.
Lin-Zhi International.................. LZI Benzodiazepine Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Oxazepam, High
Calibrator Ref# S0135c.
Lin-Zhi International.................. LZI Benzodiazepine Calibrator/ Dropper bottle: 5 mL..... 2/26/2026
Control (Oral Fluid)
Oxazepam, Intermediate
Calibrator/Level 2 Control
Ref# S0138c.
Lin-Zhi International.................. LZI Benzodiazepine Calibrator/ Dropper bottle: 5 mL..... 2/26/2026
Control (Oral Fluid)
Oxazepam, Low Calibrator/
Level 1 Control Ref# S0137c.
Lin-Zhi International.................. LZI Cocaine Metabolite Dropper bottle: 5 mL..... 2/27/2026
Calibrator (Oral Fluid)
Benzoylecgonine, Cutoff
Calibrator Ref# S0034d.
Lin-Zhi International.................. LZI Cocaine Metabolite Dropper bottle: 5 mL..... 2/27/2026
Calibrator (Oral Fluid)
Benzoylecgonine, High
Calibrator Ref# S0036d.
Lin-Zhi International.................. LZI Cocaine Metabolite Dropper bottle: 5 mL..... 2/27/2026
Calibrator (Oral Fluid)
Benzoylecgonine, Intermediate
Calibrator Ref# S0035d.
Lin-Zhi International.................. LZI Cocaine Metabolite Dropper bottle: 5 mL..... 2/27/2026
Calibrator (Oral Fluid)
Benzoylecgonine, Low
Calibrator Ref# S0033d.
Lin-Zhi International.................. LZI Cocaine Metabolite Control Dropper bottle: 5 mL..... 2/27/2026
(Oral Fluid) Benzoylecgonine,
Level 1 Control Ref# S0037d.
Lin-Zhi International.................. LZI Cocaine Metabolite Control Dropper bottle: 5 mL..... 2/27/2026
(Oral Fluid) Benzoylecgonine,
Level 2 Control Ref# S0038d.
Lin-Zhi International.................. LZI Fentanyl Calibrator Dropper bottle: 5 mL..... 2/27/2026
(Urine) Fentanyl, Cutoff
Calibrator Ref# 0993.
Lin-Zhi International.................. LZI Fentanyl Calibrator Dropper bottle: 5 mL..... 2/27/2026
(Urine) Fentanyl, High
Calibrator Ref# 0995.
Lin-Zhi International.................. LZI Fentanyl Calibrator Dropper bottle: 5 mL..... 2/27/2026
(Urine) Fentanyl,
Intermediate Calibrator Ref#
0994.
Lin-Zhi International.................. LZI Fentanyl Calibrator/ Dropper bottle: 5 mL..... 2/27/2026
Control (Urine) Fentanyl, Low
Calibrator/Level 1 Control
Ref# 0992.
Lin-Zhi International.................. LZI Fentanyl Control (Urine) Dropper bottle: 5 mL..... 2/27/2026
Fentanyl, Level 2 Control
Ref# 0998.
Lin-Zhi International.................. LZI Norfentanyl Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Urine), Norfentanyl, Cutoff
Calibrator, Ref# 0563.
Lin-Zhi International.................. LZI Norfentanyl Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Urine), Norfentanyl, High
Calibrator, Ref# 0565.
Lin-Zhi International.................. LZI Norfentanyl Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Urine), Norfentanyl,
Intermediate Calibrator, Ref#
0564.
Lin-Zhi International.................. LZI Norfentanyl Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Urine), Norfentanyl, Low
Calibrator, Ref# 0562.
Lin-Zhi International.................. LZI Norfentanyl Control Dropper bottle: 5 mL..... 2/26/2026
(Urine), Norfentanyl, Level 1
Control, Ref# 0567.
Lin-Zhi International.................. LZI Norfentanyl Control Dropper bottle: 5 mL..... 2/26/2026
(Urine), Norfentanyl, Level 2
Control, Ref# 0568.
Lin-Zhi International.................. LZI Opiate Calibrator (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) Morphine, Cutoff
Calibrator Ref# S0023c.
Lin-Zhi International.................. LZI Opiate Calibrator (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) Morphine, High
Calibrator Ref# S0025c.
Lin-Zhi International.................. LZI Opiate Calibrator (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) Morphine, Intermediate
Calibrator Ref# S0024c.
Lin-Zhi International.................. LZI Opiate Calibrator (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) Morphine, Low
Calibrator Ref# S0022c.
Lin-Zhi International.................. LZI Opiate Control (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) Morphine, Level 1
Control Ref# S0027c.
Lin-Zhi International.................. LZI Opiate Control (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) Morphine, Level 2
Control Ref# S0028c.
Lin-Zhi International.................. LZI Phencyclidine Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Phencyclidine,
Cutoff Calibrator Ref# S0013c.
Lin-Zhi International.................. LZI Phencyclidine Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Phencyclidine,
High Calibrator Ref# S0015c.
Lin-Zhi International.................. LZI Phencyclidine Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Phencyclidine,
Intermediate Calibrator Ref#
S0014c.
Lin-Zhi International.................. LZI Phencyclidine Calibrator Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Phencyclidine,
Low Calibrator Ref# S0012c.
Lin-Zhi International.................. LZI Phencyclidine Control Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Phencyclidine,
Level 1 Control Ref# S0017c.
Lin-Zhi International.................. LZI Phencyclidine Control Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) Phencyclidine,
Level 2 Control Ref# S0018c.
Lin-Zhi International.................. Multi-Analyte DAU Calibrator Dropper bottle: 15 mL.... 3/2/2026
Set E, Multi-Analyte, Cutoff
Calibrator Ref# 0893.
Lin-Zhi International.................. Multi-Analyte DAU Calibrator Dropper bottle: 15 mL.... 3/2/2026
Set E, Multi-Analyte, High
Calibrator Ref# 0895.
Lin-Zhi International.................. Multi-Analyte DAU Calibrator Dropper bottle: 15 mL.... 3/2/2026
Set E, Multi-Analyte,
Intermediate Calibrator Ref#
0894.
Lin-Zhi International.................. Multi-Analyte DAU Calibrator Dropper bottle: 15 mL.... 3/2/2026
Set E, Multi-Analyte, Level 1
Calibrator Ref# 0897.
Lin-Zhi International.................. Multi-Analyte DAU Calibrator Dropper bottle: 15 mL.... 3/2/2026
Set E, Multi-Analyte, Level 2
Calibrator Ref# 0898.
Lin-Zhi International.................. Multi-Analyte DAU Calibrator Dropper bottle: 15 mL.... 3/2/2026
Set E, Multi-Analyte, Low
Calibrator Ref# 0892.
Lin-Zhi International.................. Oral Fluid 6-Acetylmorphine Dropper bottle: 5 mL..... 2/26/2026
Calibrator 6-Acetylmorphine,
Cutoff Calibrator Ref# S0293.
Lin-Zhi International.................. Oral Fluid 6-Acetylmorphine Dropper bottle: 5 mL..... 2/26/2026
Calibrator 6-Acetylmorphine,
High Calibrator Ref# S0295.
[[Page 29509]]
Lin-Zhi International.................. Oral Fluid 6-Acetylmorphine Dropper bottle: 5 mL..... 2/26/2026
Calibrator 6-Acetylmorphine,
Intermediate Calibrator Ref#
S0294.
Lin-Zhi International.................. Oral Fluid 6-Acetylmorphine Dropper bottle: 5 mL..... 2/26/2026
Calibrator/Control 6-
Acetylmorphine, Low
Calibrator/Level 1 Control
Ref# S0292.
Lin-Zhi International.................. Oral Fluid 6-Acetylmorphine Dropper bottle: 5 mL..... 2/26/2026
Control 6-Acetylmorphine,
Level 2 Control Ref# S0297.
Lin-Zhi International.................. Oral Fluid Amphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Amphetamine,
Cutoff Calibrator Ref# S0043b.
Lin-Zhi International.................. Oral Fluid Amphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Amphetamine, High
Calibrator Ref# S0045b.
Lin-Zhi International.................. Oral Fluid Amphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Amphetamine,
Intermediate Calibrator Ref#
S0044b.
Lin-Zhi International.................. Oral Fluid Amphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Amphetamine, Low
Calibrator Ref# S0042b.
Lin-Zhi International.................. Oral Fluid Amphetamine Control Dropper bottle: 5 mL..... 2/26/2026
Amphetamine, Level 1 Control
Ref# S0046b.
Lin-Zhi International.................. Oral Fluid Amphetamine Control Dropper bottle: 5 mL..... 2/26/2026
Amphetamine, Level 2 Control
Ref# S0047b.
Lin-Zhi International.................. Oral Fluid Methamphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Methamphetamine,
Cutoff Calibrator Ref# S0053b.
Lin-Zhi International.................. Oral Fluid Methamphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Methamphetamine,
High Calibrator Ref# S0055b.
Lin-Zhi International.................. Oral Fluid Methamphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Methamphetamine,
Intermediate Calibrator Ref#
S0054b.
Lin-Zhi International.................. Oral Fluid Methamphetamine Dropper bottle: 5 mL..... 2/26/2026
Calibrator Methamphetamine,
Low Calibrator Ref# S0052b.
Lin-Zhi International.................. Oral Fluid Methamphetamine Dropper bottle: 5 mL..... 2/26/2026
Control Methamphetamine,
Level 1 Control Ref# S0056b.
Lin-Zhi International.................. Oral Fluid Methamphetamine Dropper bottle: 5 mL..... 2/26/2026
Control Methamphetamine,
Level 2 Control Ref# S0057b.
Microgenics Corporation................ MAS\TM\ Omni<bullet>IMMUNE\TM\ Glass bottle: 5 mL....... 1/16/2026
Control, Level 1.
Microgenics Corporation................ MAS\TM\ Omni<bullet>IMMUNE\TM\ Glass bottle: 5 mL....... 1/16/2026
Control, Level 2.
Microgenics Corporation................ MAS\TM\ Omni<bullet>IMMUNE\TM\ Glass bottle: 5 mL....... 1/16/2026
Control, Level 3.
RTI International...................... OF26-01....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-02....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-03....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-04....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-05....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-06....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-07....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-08....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-09....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-10....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-11....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-12....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-13....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-14....................... HDPE vials: 3 mL......... 2/17/2026
RTI International...................... OF26-15....................... HDPE vials: 3 mL......... 2/17/2026
----------------------------------------------------------------------------------------------------------------
The Assistant Administrator has found that each of the compounds,
mixtures, and preparations described in Chart II, below, is not
consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21
CFR 1308.23. Accordingly, the Assistant Administrator has determined
that the chemical preparations or mixtures generally described in Chart
II, below, and specifically described in the application materials
received by DEA, are not exempt from application of any part of the CSA
or from application of any part of the CFR, with regard to the
requested exemption pursuant to 21 CFR 1308.23, as of the date that was
provided in the determination letters to the individual requesters.
Chart II
----------------------------------------------------------------------------------------------------------------
Application
Supplier name Product name Form date
----------------------------------------------------------------------------------------------------------------
Lin-Zhi International.................. LZI Ecstasy Calibrator (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) MDMA, Cutoff
Calibrator Ref# S0163.
Lin-Zhi International.................. LZI Ecstasy Calibrator (Oral Dropper bottle: 5 mL..... 2/26/2026
Fluid) MDMA, High Calibrator
Ref# S0165.
Lin-Zhi International.................. LZI Ecstasy Calibrator/Control Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) MDMA,
Intermediate Calibrator/Level
2 Control Ref# S0168.
Lin-Zhi International.................. LZI Ecstasy Calibrator/Control Dropper bottle: 5 mL..... 2/26/2026
(Oral Fluid) MDMA, Low
Calibrator/Level 1 Control
Ref# S0167.
Microgenics Corporation................ 1 mg/mL Phencyclidine......... Kit: Glass bottles,10 mL, 2/16/2026
50 mL, 100 mL, 250 mL.
Microgenics Corporation................ 5 mg/mL Benzoylecgonine....... Kit: Glass bottles, 5 2/16/2026
mL,10 mL, 50 mL, 100 mL,
250 mL.
Microgenics Corporation................ 5 mg/mL d-Methamphetamine..... Kit: Glass bottles, 50 2/16/2026
mL, 100 mL, 250 mL.
Microgenics Corporation................ 5 mg/mL Methadone Stock....... Kit: Glass bottles, 25 2/16/2026
mL, 50 mL, 100 mL, 250
mL.
[[Page 29510]]
Microgenics Corporation................ 5 mg/mL Morphine.............. Kit: Glass bottles, 50 2/16/2026
mL, 100 mL, 250 mL, 500
mL.
Microgenics Corporation................ Benzoylecgonine (Cocaine) Kit: Glass bottles, 5 2/16/2026
Control Stock Solution 5mg/mL. mL,10 mL, 50 mL, 100 mL,
250 mL.
Microgenics Corporation................ Methadone Control Stock Kit: Glass bottles, 25 2/16/2026
Solution (5mg/mL). mL, 50 mL, 100 mL, 250
mL.
Microgenics Corporation................ Methamphetamine (Amphetamines) Kit: Glass bottles, 5 2/16/2026
Control Stock Solution (5 mg/ mL,10 mL, 50 mL, 100 mL,
mL). 250 mL.
Microgenics Corporation................ Morphine (Opiate) Control Kit: Glass bottles, 10 2/16/2026
Stock Solution (5 mg/mL). mL, 25 mL, 50 mL, 100
mL, 250 mL, 500 mL.
Microgenics Corporation................ PCP Control Stock Solution Kit: Glass bottles, 10 2/16/2026
(1mg/mL). mL, 50 mL, 100 mL.
Purisys, LLC........................... 1 mg/mL D9-THC in methanol.... Bottle: 50 g............. 2/25/2026
Restek Corporation..................... HC [Delta]9-THC Stock 50,000 Glass ampoule: 1.3 mL.... 3/10/2026
[mu]g/mL).
----------------------------------------------------------------------------------------------------------------
Opportunity for Comment
Pursuant to 21 CFR 1308.23(e), any interested person may submit
written comments on or objections to any chemical preparation in this
order that has been approved or denied as exempt. If any comments or
objections raise significant issues regarding any finding of fact or
conclusion of law upon which this order is based, the Assistant
Administrator will immediately suspend the effectiveness of any
applicable part of this order until she may reconsider the application
in light of the comments and objections filed. Thereafter, the
Assistant Administrator shall reinstate, revoke, or amend his original
order as she determines appropriate.
Approved Exempt Chemical Preparations Are Posted on DEA's Website
A list of all current exemptions, including those listed in this
order, is available on DEA's website at <a href="http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf">http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf</a>. The
dates of applications of all current exemptions are posted for easy
reference.
Signing Authority
This document of the Drug Enforcement Administration was signed on
May 14, 2026, by DEA Assistant Administrator Cheri Oz. That document
with the original signature and date is maintained by DEA. For
administrative purposes only, and in compliance with requirements of
the Office of the Federal Register, the undersigned DEA Federal
Register Liaison Officer has been authorized to sign and submit the
document in electronic format for publication, as an official document
of DEA. This administrative process in no way alters the legal effect
of this document upon publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2026-10090 Filed 5-19-26; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on May 20, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.